07:00 , Apr 10, 2000 |  BC Week In Review  |  Company News

Allergan, Dura sales and marketing update

DURA began promoting to primary care physicians and allergists AGN's Alocril nedocromil ophthalmic solution to treat itch associated with allergic conjunctivitis. AGN will market the product to ophthalmologists (see BioCentury, Feb. 28). Allergan Inc. (AGN),...
08:00 , Feb 28, 2000 |  BC Week In Review  |  Company News

Allergan, Dura sales and marketing update

The companies will commercialize certain AGN products for the U.S. primary care and respiratory markets. In March, the companies will co-launch AGN's Alocril nedocromil ophthalmic solution to treat itch associated with allergic conjunctivitis, with AGN...
08:00 , Feb 23, 2000 |  BC Extra  |  Company News

Dura and Allergan in product co-promotion

The companies agreed to commercialize certain AGN products in the U.S. primary care and respiratory markets. In March, the companies will co-launch Alocril nedocromil ophthalmic solution to treat itch associated with allergic conjunctivitis, with AGN...